| The Exosome Total Isolation Chip F Liu, O Vermesh, V Mani, TJ Ge, SJ Madsen, A Sabour, EC Hsu, ... ACS nano 11 (11), 10712-10723, 2017 | 311 | 2017 |
| Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer A Ghoochani, EC Hsu, M Aslan, MA Rice, HM Nguyen, JD Brooks, ... Cancer research 81 (6), 1583-1594, 2021 | 171 | 2021 |
| PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis HW Yeh, EC Hsu, SS Lee, YD Lang, YC Lin, CY Chang, SY Lee, DL Gu, ... Nature cell biology 20 (4), 479-491, 2018 | 161 | 2018 |
| Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator KH Lee, EC Hsu, JH Guh, HC Yang, D Wang, SK Kulp, CL Shapiro, ... Journal of Biological Chemistry 286 (45), 39247-39258, 2011 | 122 | 2011 |
| Preclinical investigation of the novel histone deacetylase inhibitor AR-42 in the treatment of cancer-induced cachexia YC Tseng, SK Kulp, IL Lai, EC Hsu, WA He, DE Frankhouser, PS Yan, ... Journal of the National Cancer Institute 107 (12), djv274, 2015 | 118 | 2015 |
| Identification and characterization of a novel integrin-linked kinase inhibitor SL Lee, EC Hsu, CC Chou, HC Chuang, LY Bai, SK Kulp, CS Chen Journal of medicinal chemistry 54 (18), 6364-6374, 2011 | 113 | 2011 |
| Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1 EC Hsu, MA Rice, A Bermudez, FJG Marques, M Aslan, S Liu, ... Proceedings of the National Academy of Sciences 117 (4), 2032-2042, 2020 | 106 | 2020 |
| Gold Nanoclusters for NIR‐II Fluorescence Imaging of Bones D Li, Q Liu, Q Qi, H Shi, EC Hsu, W Chen, W Yuan, Y Wu, S Lin, Y Zeng, ... Small 16 (43), 2003851, 2020 | 101 | 2020 |
| Overlapping high‐resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma CF Chen, EC Hsu, KT Lin, PH Tu, HW Chang, CH Lin, YJ Chen, DL Gu, ... Hepatology 52 (5), 1690-1701, 2010 | 69 | 2010 |
| Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer T Stoyanova, M Riedinger, S Lin, CM Faltermeier, BA Smith, KX Zhang, ... Proceedings of the National Academy of Sciences 113 (42), E6457-E6466, 2016 | 54 | 2016 |
| Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6–Abundant Breast Cancer Cells by Regulating γ-Secretase–Mediated Notch1 Activation in Caveolae EC Hsu, SK Kulp, HL Huang, HJ Tu, SB Salunke, NJ Sullivan, D Sun, ... Neoplasia 17 (6), 497-508, 2015 | 49 | 2015 |
| Loss of Notch1 activity inhibits prostate cancer growth and metastasis and sensitizes prostate cancer cells to antiandrogen therapies MA Rice, EC Hsu, M Aslan, A Ghoochani, A Su, T Stoyanova Molecular cancer therapeutics 18 (7), 1230-1242, 2019 | 48 | 2019 |
| Plectin is a regulator of prostate cancer growth and metastasis M Buckup, MA Rice, EC Hsu, F Garcia-Marques, S Liu, M Aslan, ... Oncogene 40 (3), 663-676, 2021 | 37 | 2021 |
| Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability MW Chao, PC Chu, HC Chuang, FH Shen, CC Chou, EC Hsu, LE Himmel, ... Oncotarget 7 (2), 1796, 2016 | 35 | 2016 |
| Repression of hepatitis B viral gene expression by transcription factor nuclear factor‐kappaB YC Lin, EC Hsu, LP Ting Cellular microbiology 11 (4), 645-660, 2009 | 32 | 2009 |
| PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression YD Lang, HY Chen, CM Ho, JH Shih, EC Hsu, R Shen, YC Lee, JW Chen, ... Nature Communications 10 (1), 5716, 2019 | 31 | 2019 |
| Integrin-linked kinase as a novel molecular switch of the IL-6-NF-κB signaling loop in breast cancer EC Hsu, SK Kulp, HL Huang, HJ Tu, MW Chao, YC Tseng, MC Yang, ... Carcinogenesis 37 (4), 430-442, 2016 | 28 | 2016 |
| Oncogene-mediated metabolic gene signature predicts breast cancer outcome M Aslan, EC Hsu, FJ Garcia-Marques, A Bermudez, S Liu, M Shen, ... NPJ breast cancer 7 (1), 141, 2021 | 26 | 2021 |
| Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer S Liu, M Shen, EC Hsu, CA Zhang, F Garcia-Marques, R Nolley, K Koul, ... British Journal of Cancer 124 (5), 896-900, 2021 | 24 | 2021 |
| MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer EC Hsu, M Shen, M Aslan, S Liu, M Kumar, F Garcia-Marques, ... Scientific Reports 11 (1), 13305, 2021 | 21 | 2021 |
